ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0575

The Impact of an Integrated Care Management Program on Acute Care Utilization and Outpatient Appointment Attendance Among High-Risk Patients with Lupus

Jessica Williams1, Weixing Huang2, Jamie Collins3, Kreager Taber1, Katherine McLaughlin1, Rebecca Cunningham1, Christine Vogeli4, Lisa Wichmann1 and Candace Feldman3, 1Brigham and Women's Hospital, Boston, MA, 2Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, 3Brigham and Women's Hospital, Boston, 4Massachusetts General Hospital, Boston, MA

Meeting: ACR Convergence 2020

Keywords: Access to care, Disparities, Health Services Research, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: Health Services Research Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with systemic lupus erythematosus (SLE) are often members of disadvantaged groups and some struggle with high acute care utilization and missed outpatient appointments. An integrated care management program (iCMP) was established at our multihospital system whereby nurses lead care coordination efforts for patients considered high risk for frequent emergency department (ED) visits and hospitalizations. We aimed to determine whether this program was effective at decreasing acute medical care use and outpatient no-show rates among patients with SLE.

Methods: The top two percent of medically and psychosocially complex patients within our multihospital system are enrolled in iCMP – a longitudinal primary care-embedded care management program. We used a validated electronic health record (EHR) machine learning algorithm (PPV 90%) to identify adults ≥18 with SLE enrolled in iCMP from January 2012-February 2019 and verified the diagnosis with EHR review. We used EHR data linked to insurance claims to compare the incidence rates of ED visits, hospitalizations, 30-day readmissions, and outpatient appointment no-shows during iCMP enrollment to the 12-months prior. We used Poisson regression to examine the incidence rate ratios (IRR) during versus pre-iCMP enrollment for each of these utilization measures, adjusting for age, sex, race/ethnicity, number of comorbidities and calendar year of entry, accounting for within-patient clustering.

Results: We identified 67 iCMP enrollees with SLE and linked EHR-claims data. Fifty-five met 1997 ACR criteria for SLE, 9 met 2012 SLICC criteria, and 3 did not meet criteria but were diagnosed and treated by a rheumatologist. The mean duration of iCMP enrollment was 46 (SD 29) months. The mean age was 60 (SD 17) years and 93% were female. Enrollees were 55% white, 25% black, 16% other race and 3% Asian, and 21% were Hispanic. Twenty patients had commercial insurance, 59 had Medicare, 4 had Medicaid and 16 had ≥1 one insurance. The rate of ED visits averaged 0.14/person-month during iCMP enrollment compared to 0.20/person-month pre-iCMP (IRR 0.66, 95% CI 0.48-0.92, p=0.01), the rate of hospitalizations averaged 0.10/person-month during iCMP compared to 0.12/person-month pre (IRR 0.89, 95% CI 0.64-1.24, p=0.5), and the rate of outpatient appointment no-shows was 0.09/person-month during iCMP compared to 0.14/person-month pre (IRR 0.74, 95% CI 0.57-0.97, p=0.03); see Figure. After adjusting for demographics, enrollment year, comorbidities, and repeated measures, there was a 37% reduction in the rate of ED visits during iCMP compared to the year prior (p=0.003) and trends towards reduced hospitalizations (IRR 0.88, 95% CI 0.65-1.19, p=0.39) and fewer missed appointments (IRR 0.80, 95% CI 0.62-1.04, p=0.097).

Conclusion: In a single arm, pre-post observational study, we found that a nurse-led, primary care-based integrated care management program appeared effective at decreasing the rate of ED visits for high-risk SLE patients and likely also reduced rates of missed appointments. Further studies are needed to determine the root causes of high utilization patterns for vulnerable patients and to develop strategies to comprehensively address these issues.


Disclosure: J. Williams, None; W. Huang, None; J. Collins, None; K. Taber, None; K. McLaughlin, None; R. Cunningham, None; C. Vogeli, None; L. Wichmann, None; C. Feldman, Merck, 5, Voyager Therapeutics, 5, Biogen, 8.

To cite this abstract in AMA style:

Williams J, Huang W, Collins J, Taber K, McLaughlin K, Cunningham R, Vogeli C, Wichmann L, Feldman C. The Impact of an Integrated Care Management Program on Acute Care Utilization and Outpatient Appointment Attendance Among High-Risk Patients with Lupus [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/the-impact-of-an-integrated-care-management-program-on-acute-care-utilization-and-outpatient-appointment-attendance-among-high-risk-patients-with-lupus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-an-integrated-care-management-program-on-acute-care-utilization-and-outpatient-appointment-attendance-among-high-risk-patients-with-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology